DLL3 and metastatic malignant neoplasm in the lymph nodes: There was no marked difference in the sex, smoking status, surgical procedure, pathological stage, pathological tumor size, or rate of lymph node metastasis, pleural invasion, or vascular invasion between the patients with DLL3 expression‐positive and expression‐negative LCNEC.